| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―Jan―13 |
Do Levels of the Platelet Activation Markers sCD40 L and SCUBE 1 Differ between Laboratory-Confirmed and Clinically Diagnosed COVID-19 Patients? |
Özkan G, Bayrakçi N, Mutlu LC, Erdem I, Tuna N, Dogan M, et al. (+5) Yildirim I, Erdal B, çelikkol A, Yilmaz A, Güzel S |
| 2 |
[GO] |
2023―Jan―13 |
Disease Course and Patient’s Characteristics in a Regional First Level Hospital in Western-Germany During the First Three Covid-19 Surges from March 2020 to July 2021 |
Goller Julia, Ratayczak Mark, Dahlem Markus, Bracko M, Ballmann Clemens, Middeldorf Thomas, et al. (+5) Lengfeld Hendrik, Ess Gabriele, Bill Oliver, Tekin G, Schmitz Volker |
| 3 |
[GO] |
2021―Jun―28 |
Potential Benefit of Soluble Thrombomodulin in Coping with COVID-19/SARS-CoV-2-Induced Coagulopathy |
Mori H, Ikezoe T |
| 4 |
[GO] |
2021―May―07 |
Biological Markers Associated with Pulmonary Embolism in COVID-19 |
Moises J, Blanco I, Garcia AR, Sanchez M, Aibar J, Benegas M, et al. (+8) Andrea R, Badia JR, Castro P, Fernandez J, Sonia Jimenez, Soriano A, Reverter JC, Barbera JA |
|
